Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas

British Journal of Ophthalmology

Volumn 93, Issue 9, 2009, Pages 1167-1171

  Kaiserman, N ^a   Kaiserman, I ^b   Hendler, K ^a   Frenkel, S ^a   Pe'er, J ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b BARZILAI MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

RUTHENIUM 106; RUTHENIUM DERIVATIVE; RUTHENIUM TETROXIDE;

ADULT; ARTICLE; BRACHYTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CONTROLLED STUDY; ENUCLEATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEOVASCULAR GLAUCOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE; SAFETY; SCLERA DISEASE; SCLERA MELT; TUMOR GROWTH; UVEA MELANOMA; VISUAL ACUITY; VITREOUS HEMORRHAGE; COMPARATIVE STUDY; KAPLAN MEIER METHOD; MELANOMA; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; STATISTICS; TREATMENT OUTCOME; TUMOR RECURRENCE; UVEA TUMOR;

BRACHYTHERAPY; EYE ENUCLEATION; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RUTHENIUM COMPOUNDS; TREATMENT OUTCOME; UVEAL NEOPLASMS; VISUAL ACUITY;

EID: 70249115595     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2009.157701     Document Type: Article

References (22)

1. Shields CL, Naseripour M, Cater J, et al. Plaque radiotherapy for large posterior uveal melanomas (> or = 8 mm thick) in 354 consecutive patients. Ophthalmology 2002;109:1838-1849.
2. Diener West M, Earle JD, Fine SL, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch Ophthalmol 2001;119:969-982
3. Jampol LM, Moy CS, Murray TG, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no.19. Ophthalmology 2002;109:2197-2206
4. Puusaari I, Heikkonen J, Summanen P, et al. Iodine Brachytherapy as an alternative to enucleation for large uveal melanomas. Ophthalmology 2003;110:2223-2234 (Pubitemid 37337863)
5. Fontanesi J, Meyer D, Xu S, et al. Treatment of choroidal melanoma with I-125 plaque. Int J Radiat Oncol Biol Phys 1993;26:619-623 (Pubitemid 23220159)
6. Reader S, Grigg J, Billson FA. Choroidal melanoma: a review of the experience of the Sydney Eye Hospital Professorial Unit 1979-1995. Aust N Z J Ophthalmol 1997;25:15-24.
7. Lommatzsch P, Vollmar R. A new way in the conservative therapy of intraocular tumors by means of beta-irradiation (Ruthenium 106) with preservation of vision. Klin Monatsbl Augenheilkd 1966;148:682-699
8. Hall EJ, ed. Radiobiology for the radiologist. Philadelphia: JB Lippincott, 1994:1-14.
9. Bechrakis NE, Bornfeld N, Zoller I, et al. Iodine 125 plaque brachytherapy versus transscleral tumor resection in the treatment of large uveal melanomas. Ophthalmology 2002;109:1855-1861
10. Nag S, Quivey JM, Earle JD, et al. The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas. Int J Radiat Oncol Biol Phys 2003;56:544-555 (Pubitemid 36542915)
11. Summanen P, Immonen I, Heikkonen J, et al. Survival of patients and metastatic and local recurrent tumor growth in malignant melanoma of the uvea after ruthenium plaque radiotherapy. Ophthalmol Surg 1993;24:82-90. (Pubitemid 23088547)
12. Guthoff R, Bentzen SM. Rates of local control, metastasis, and overall survival in patients with posterior uveal melanomas treated with ruthenium-106 plaques. Radiother Oncol 1993;28:148-156 (Pubitemid 23297750)
13. Ossoinig KC. Standardized echography: basic principles, clinical applications, and results. Int Ophthalmol Clin 1979;19:127-210.
14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481
15. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-170
16. Cox DR. Regression models and life-tables. J R Stat Soc B 1972;34:187-220.
17. Seregard S. Long-term survival after ruthenium plaque radiotherapy for uveal melanoma. A meta-analysis of studies including 1066 patients. Acta Ophthalmol Scand 1999;77:414-417
18. Collaborative Ocular Melanoma Study Group. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings. COMS report no. 10. Am J Ophthalmol 1998;125:779-796 (Pubitemid 28283740)
19. Rouberol F, Roy P, Kodjikian L, et al. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays). Am J Ophthalmol 2004;137:893-900. (Pubitemid 38582043)
20. 125I plaques for treatment of shallow (< or = 5 mm) choroidal melanoma lesions. Br J Radiol 2008;81:784-789
21. Avery RB, Diener-West M, Reynolds SM, et al. Histopathologic characteristics of choroidal melanoma in eyes enucleated after iodine 125 brachytherapy in the collaborative ocular melanoma study. Arch Ophthalmol 2008;126:207-212 (Pubitemid 351240849)
22. Messmer E, Bornfeld N, Foerster M, et al. Histopathologic findings in eyes treated with a ruthenium plaque for uveal melanoma. Graefes Arch Clin Exp Ophthalmol 1992;230:391-396